The nominations for this year's The Pathologist Power List will be opening on Friday March 22, 2024.
Results from early access trials demonstrate the reproducibility and reliability of a pan-cancer next-generation sequencing assay
A tumor gene test has been developed that may predict poor survival in patients with ovarian cancer
To improve immunotherapy outcomes, we need to explore new biomarkers that offer spatial resolution in the tumor microenvironment
Two experts in childhood cancers give their take on the intricacies of pediatric laboratory medicine and where they think the field will go next
As the UK heads toward test centralization, medical oncologist Tanya Ahmad explains why in-house testing shouldn’t be left behind
A new algorithm may help identify rare circulating tumor cells to improve liquid biopsy
Heather D. Couture
New AI technology uses H&E images to create an alternative path for molecular diagnostics
Liquid biopsy is minimally invasive and easily accessible – but what information can a new multiplexed assay provide from circulating tumor DNA?
by Adaptive Biotechnologies
Minimal residual disease testing by immunosequencing can yield vital information about patients’ disease and management
by Thermo Fisher Scientific
In-house testing offers labs the ability to research, educate, and achieve complete coordination with clinical colleagues
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
“I Learned It from TikTok”
Ring the Changes